Skip to main content

ORIGINAL RESEARCH article

Front. Psychiatry
Sec. ADHD
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1534280

Somatic Comorbidities and health related uncertainty among Swedish Adolescents with ADHD

Provisionally accepted
sara Lundqvist sara Lundqvist 1*sara Röjås sara Röjås 2*Kourosh Bador Kourosh Bador 3Maria Rastam Maria Rastam 4*Nóra Kerekes Nóra Kerekes 5
  • 1 Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Göteborg, Västergötland, Sweden
  • 2 department of child and adolescent psychiatri Sahlgrenska university hospital, Göteborg, Sweden
  • 3 Centre for Holistic Psychiatry Research (CHoPy) Gothenburg, Gothenburg, Sweden
  • 4 Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Skane County, Sweden
  • 5 University West, Trollhättan, Sweden

The final, formatted version of the article will be published soon.

    Introduktion: Attention-deficit/hyperactivity disorder (ADHD) frequently exists alongside psychiatric comorbidities. The coexistence of somatic diseases and ADHD constitutes a growing field of research. Method: This study aimed to examine the prevalence of common somatic diseases in adolescents with ADHD and compare them with those in adolescents without any psychiatric diagnoses. A cross-sectional study was conducted among a convenient sample of Swedish upper secondary school students aged 15 to 19 years. Data were collected using an electronic version of the “Mental and Somatic Health without borders” survey. In 2020, 1608 adolescents completed the survey and provided self-reports of their psychiatric and somatic diagnoses. Results: Among the sample of Swedish adolescents, 5.5% reported having ADHD diagnoses. These adolescents reported more somatic comorbidities than those wihout any psychiatric diagnosis (comparison group). The most common somatic comorbidities among those with ADHD were allergies (43.4%), asthma (24.7%), and skin diseases (16.7%), which prevalences were significantly higher than those reported by adolescents in the comparison group. However the effect sizes of these differences were negligible (allergies: p=0.002, Cramer’s V=0.08; asthma: p=0.041, Cramer’s V=0.06; skin diseases: p=0.007, Cramer’s V=0.08), raising questions about the practical implications of these findings. Allergies were significantly more common in both genders with ADHD (p=0.038, Cramer’s V=0.08 in women and p=0.038, Cramer’s V=0.09 in man), with man showing a significant association with skin diseases (p=0.007, Cramer’s V=0.12) and women with migraine (p=0.038, Cramer’s V=0.08). Notably, adolescents with ADHD reported significantly higher rates of uncertainty regarding the existence of diabetes, rheumatoid diseases, asthma (with negligible effect sizes), and thyroid diseases (with a small effect size) than those without any psychiatric diagnoses, suggesting heightened health reslated anxiety within this group. Conclusions: Adolescents with ADHD reported more somatic comorbidities and greater uncertenty about the potential presence of additional somatic conditions compared to adolescents without psychiatric diagnoses. These findings highlight the importance of addressing both health literacy and access to healthcare. By focusing on this group, it is possible not only to improve their ability to understand and navigate the healthcare system but also to strengthen their confidence in managing their own health

    Keywords: adolescents, allergies, Health uncertenty, Attention-deficit/hyperactivity disorder (ADHD), gender, Migrain, Skin Diseases

    Received: 25 Nov 2024; Accepted: 13 Jan 2025.

    Copyright: © 2025 Lundqvist, Röjås, Bador, Rastam and Kerekes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    sara Lundqvist, Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Göteborg, SE413 45, Västergötland, Sweden
    sara Röjås, department of child and adolescent psychiatri Sahlgrenska university hospital, Göteborg, Sweden
    Maria Rastam, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, 221 84, Skane County, Sweden

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.